Back to top Open menu arrow
Download Reprints
Sections
METHODS RESULTS DISCUSSION Clinical Points
The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry
Access icon

Original Research Childhood and Adolescent Mental Health May 3, 2023

Lower Ghrelin Levels Are Associated With Higher Anxiety Symptoms in Adolescents and Young Adults With Avoidant/Restrictive Food Intake Disorder

Aluma Chovel Sella, MD; Natalia Hadaway, BS; Casey Stern, BS; Kendra R. Becker, PhD; Laura M. Holsen, PhD; Kamryn T. Eddy, PhD; Nadia Micali, MD, PhD; Madhusmita Misra, MD, MPH; Jennifer J. Thomas, PhD; Elizabeth A. Lawson, MD, MMSc

J Clin Psychiatry 2023;84(3):22m14482

ABSTRACT

Objective: Avoidant/restrictive food intake disorder (ARFID) is associated with increased risk for anxiety, which may adversely affect prognosis. The appetite-stimulating hormone, ghrelin, increases in response to stress, and exogenous ghrelin decreases anxiety-like behaviors in animal models. The aim of this study was to evaluate the relationship between ghrelin levels and measures of anxiety in youth with ARFID. We hypothesized that lower ghrelin levels would be associated with increased anxiety symptoms.

Methods: We studied a cross-sectional sample of 80 subjects with full and subthreshold ARFID diagnosed by DSM-5 criteria, aged 10–23 years (female, n = 39; male, n = 41). Subjects were enrolled in a study of the neurobiology of avoidant/restrictive eating conducted from August 2016 to January 2021. We assessed fasting ghrelin levels and anxiety symptoms (State-Trait Anxiety Inventory [STAI] and STAI for Children [STAI-C] measuring general trait anxiety; Beck Anxiety Inventory [BAI] and BAI for youth [BAI-Y] assessing cognitive, emotional, and somatic symptoms of anxiety; and Liebowitz Social Anxiety Scale [LSAS] assessing symptoms of social anxiety).

Results: Consistent with our hypothesis, ghrelin levels were inversely associated with anxiety symptoms as assessed by STAI/STAI-C T scores (r = −0.28, P = .012), BAI/BAI-Y T scores (r = −0.28, P = .010), and LSAS scores (r = −0.3, P = .027), all with medium effect sizes. Findings held in the full threshold ARFID group when adjusting for body mass index z scores (STAI/STAI-C T scores, β = −0.27, P = .024; BAI/BAI-Y T scores, β = −0.26, P = .034; LSAS, β = −0.34, P = .024).

Conclusions: These findings demonstrate that lower levels of ghrelin are associated with more severe anxiety symptoms in youth with ARFID and raise the question of whether ghrelin pathways could be targeted in the treatment of ARFID.

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. American Psychiatric Association; 2013.
  2. Fisher MM, Rosen DS, Ornstein RM, et al. Characteristics of avoidant/restrictive food intake disorder in children and adolescents: a “new disorder” in DSM-5. J Adolesc Health. 2014;55(1):49–52. PubMed CrossRef
  3. Cooney M, Lieberman M, Guimond T, et al. Clinical and psychological features of children and adolescents diagnosed with avoidant/restrictive food intake disorder in a pediatric tertiary care eating disorder program: a descriptive study. J Eat Disord. 2018;6(1):7. PubMed CrossRef
  4. Nakai Y, Nin K, Noma S, et al. Clinical presentation and outcome of avoidant/restrictive food intake disorder in a Japanese sample. Eat Behav. 2017;24:49–53. PubMed CrossRef
  5. Strandjord SE, Sieke EH, Richmond M, et al. Avoidant/restrictive food intake disorder: illness and hospital course in patients hospitalized for nutritional insufficiency. J Adolesc Health. 2015;57(6):673–678. PubMed CrossRef
  6. Aulinas A, Marengi DA, Galbiati F, et al. Medical comorbidities and endocrine dysfunction in low-weight females with avoidant/restrictive food intake disorder compared to anorexia nervosa and healthy controls. Int J Eat Disord. 2020;53(4):631–636. PubMed CrossRef
  7. Nicely TA, Lane-Loney S, Masciulli E, et al. Prevalence and characteristics of avoidant/restrictive food intake disorder in a cohort of young patients in day treatment for eating disorders. J Eat Disord. 2014;2(1):21. PubMed CrossRef
  8. Kambanis PE, Kuhnle MC, Wons OB, et al. Prevalence and correlates of psychiatric comorbidities in children and adolescents with full and subthreshold avoidant/restrictive food intake disorder. Int J Eat Disord. 2020;53(2):256–265. PubMed CrossRef
  9. Norris ML, Robinson A, Obeid N, et al. Exploring avoidant/restrictive food intake disorder in eating disordered patients: a descriptive study. Int J Eat Disord. 2014;47(5):495–499. PubMed CrossRef
  10. Brand-Gothelf A, Leor S, Apter A, et al. The impact of comorbid depressive and anxiety disorders on severity of anorexia nervosa in adolescent girls. J Nerv Ment Dis. 2014;202(10):759–762. PubMed CrossRef
  11. Hughes EK, Goldschmidt AB, Labuschagne Z, et al. Eating disorders with and without comorbid depression and anxiety: similarities and differences in a clinical sample of children and adolescents. Eur Eat Disord Rev. 2013;21(5):386–394. PubMed CrossRef
  12. Sander J, Moessner M, Bauer S. Depression, anxiety and eating disorder-related impairment: moderators in female adolescents and young adults. Int J Environ Res Public Health. 2021;18(5):2779. PubMed CrossRef
  13. Kormos V, Gaszner B. Role of neuropeptides in anxiety, stress, and depression: from animals to humans. Neuropeptides. 2013;47(6):401–419. PubMed CrossRef
  14. Wehry AM, Beesdo-Baum K, Hennelly MM, et al. Assessment and treatment of anxiety disorders in children and adolescents. Curr Psychiatry Rep. 2015;17(7):52. PubMed CrossRef
  15. Dalle Grave R, Conti M, Calugi S. Effectiveness of intensive cognitive behavioral therapy in adolescents and adults with anorexia nervosa. Int J Eat Disord. 2020;53(9):1428–1438. PubMed CrossRef
  16. Hay PJ, Claudino AM, Touyz S, et al. Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa. Cochrane Database Syst Rev. 2015;2015(7):CD003909. PubMed CrossRef
  17. Zeeck A, Herpertz-Dahlmann B, Friederich HC, et al. Psychotherapeutic treatment for anorexia nervosa: a systematic review and network meta-analysis. Front Psychiatry. 2018;9:158. PubMed CrossRef
  18. Thomas JJ, Wons OB, Eddy KT. Cognitive-behavioral treatment of avoidant/restrictive food intake disorder. Curr Opin Psychiatry. 2018;31(6):425–430. PubMed CrossRef
  19. Tschöp M, Weyer C, Tataranni PA, et al. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50(4):707–709. PubMed CrossRef
  20. Stone LA, Harmatz ES, Goosens KA. Ghrelin as a stress hormone: implications for psychiatric illness. Biol Psychiatry. 2020;88(7):531–540. PubMed CrossRef
  21. Spencer SJ, Xu L, Clarke MA, et al. Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress. Biol Psychiatry. 2012;72(6):457–465. PubMed CrossRef
  22. Alvarez-Crespo M, Skibicka KP, Farkas I, et al. The amygdala as a neurobiological target for ghrelin in rats: neuroanatomical, electrophysiological and behavioral evidence. PLoS One. 2012;7(10):e46321. PubMed CrossRef
  23. Kristenssson E, Sundqvist M, Astin M, et al. Acute psychological stress raises plasma ghrelin in the rat. Regul Pept. 2006;134(2-3):114–117. PubMed CrossRef
  24. Huang CC, Chou D, Yeh CM, et al. Acute food deprivation enhances fear extinction but inhibits long-term depression in the lateral amygdala via ghrelin signaling. Neuropharmacology. 2016;101:36–45. PubMed CrossRef
  25. Asakawa A, Inui A, Kaga T, et al. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology. 2001;74(3):143–147. PubMed CrossRef
  26. Schmidt MV, Levine S, Alam S, et al. Metabolic signals modulate hypothalamic-pituitary-adrenal axis activation during maternal separation of the neonatal mouse. J Neuroendocrinol. 2006;18(11):865–874. PubMed CrossRef
  27. Meyer RM, Burgos-Robles A, Liu E, et al. A ghrelin-growth hormone axis drives stress-induced vulnerability to enhanced fear. Mol Psychiatry. 2014;19(12):1284–1294. PubMed CrossRef
  28. Yousufzai MIUA, Harmatz ES, Shah M, et al. Ghrelin is a persistent biomarker for chronic stress exposure in adolescent rats and humans. Transl Psychiatry. 2018;8(1):74. PubMed CrossRef
  29. Han QQ, Huang HJ, Wang YL, et al. Ghrelin exhibited antidepressant and anxiolytic effect via the p38-MAPK signaling pathway in hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2019;93:11–20. PubMed CrossRef
  30. Lutter M, Sakata I, Osborne-Lawrence S, et al. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci. 2008;11(7):752–753. PubMed CrossRef
  31. Huang HJ, Zhu XC, Han QQ, et al. Ghrelin alleviates anxiety- and depression-like behaviors induced by chronic unpredictable mild stress in rodents. Behav Brain Res. 2017;326:33–43. PubMed CrossRef
  32. Chuang JC, Perello M, Sakata I, et al. Ghrelin mediates stress-induced food-reward behavior in mice. J Clin Invest. 2011;121(7):2684–2692. PubMed CrossRef
  33. Rouach V, Bloch M, Rosenberg N, et al. The acute ghrelin response to a psychological stress challenge does not predict the post-stress urge to eat. Psychoneuroendocrinology. 2007;32(6):693–702. PubMed CrossRef
  34. Raspopow K, Abizaid A, Matheson K, et al. Psychosocial stressor effects on cortisol and ghrelin in emotional and non-emotional eaters: influence of anger and shame. Horm Behav. 2010;58(4):677–684. PubMed CrossRef
  35. Raspopow K, Abizaid A, Matheson K, et al. Anticipation of a psychosocial stressor differentially influences ghrelin, cortisol and food intake among emotional and non-emotional eaters. Appetite. 2014;74:35–43. PubMed CrossRef
  36. McKay NJ, Giorgianni NR, Czajka KE, et al. Plasma levels of ghrelin and GLP-1, but not leptin or amylin, respond to a psychosocial stressor in women and men. Horm Behav. 2021;134:105017. PubMed CrossRef
  37. Stark R, Santos VV, Geenen B, et al. Des-acyl ghrelin and ghrelin o-acyltransferase regulate hypothalamic-pituitary-adrenal axis activation and anxiety in response to acute stress. Endocrinology. 2016;157(10):3946–3957. PubMed CrossRef
  38. Zhang F, Xu F, Mi X, et al. Ghrelin/GHS-R1a signaling plays different roles in anxiety-related behaviors after acute and chronic caloric restriction. Biochem Biophys Res Commun. 2020;529(4):1131–1136. PubMed CrossRef
  39. Jensen M, Ratner C, Rudenko O, et al. Anxiolytic-like effects of increased ghrelin receptor signaling in the amygdala. Int J Neuropsychopharmacol. 2016;19(5):pyv123. PubMed CrossRef
  40. Kanehisa M, Akiyoshi J, Kitaichi T, et al. Administration of antisense DNA for ghrelin causes an antidepressant and anxiolytic response in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(8):1403–1407. PubMed CrossRef
  41. Hansson C, Haage D, Taube M, et al. Central administration of ghrelin alters emotional responses in rats: behavioural, electrophysiological and molecular evidence. Neuroscience. 2011;180:201–211. PubMed CrossRef
  42. Carlini VP, Monzón ME, Varas MM, et al. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem Biophys Res Commun. 2002;299(5):739–743. PubMed CrossRef
  43. Currie PJ, Khelemsky R, Rigsbee EM, et al. Ghrelin is an orexigenic peptide and elicits anxiety-like behaviors following administration into discrete regions of the hypothalamus. Behav Brain Res. 2012;226(1):96–105. PubMed CrossRef
  44. Germain N, Galusca B, Le Roux CW, et al. Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. Am J Clin Nutr. 2007;85(4):967–971. PubMed CrossRef
  45. Misra M, Miller KK, Kuo K, et al. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab. 2005;289(2):E347–E356. PubMed CrossRef
  46. Singhal V, Misra M, Klibanski A. Endocrinology of anorexia nervosa in young people: recent insights. Curr Opin Endocrinol Diabetes Obes. 2014;21(1):64–70. PubMed CrossRef
  47. Holsen LM, Lawson EA, Christensen K, et al. Abnormal relationships between the neural response to high- and low-calorie foods and endogenous acylated ghrelin in women with active and weight-recovered anorexia nervosa. Psychiatry Res. 2014;223(2):94–103. PubMed CrossRef
  48. Becker KR, Mancuso C, Dreier MJ, et al. Ghrelin and PYY in low-weight females with avoidant/restrictive food intake disorder compared to anorexia nervosa and healthy controls. Psychoneuroendocrinology. 2021;129:105243. PubMed CrossRef
  49. Ishitobi Y, Kohno K, Kanehisa M, et al. Serum ghrelin levels and the effects of antidepressants in major depressive disorder and panic disorder. Neuropsychobiology. 2012;66(3):185–192. PubMed CrossRef
  50. Hansson C, Annerbrink K, Nilsson S, et al. A possible association between panic disorder and a polymorphism in the preproghrelingene. Psychiatry Res. 2013;206(1):22–25. PubMed CrossRef
  51. Nakashima K, Akiyoshi J, Hatano K, et al. Ghrelin gene polymorphism is associated with depression, but not panic disorder. Psychiatr Genet. 2008;18(5):257. PubMed CrossRef
  52. Lawson EA, Miller KK, Blum JI, et al. Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat. Clin Endocrinol (Oxf). 2012;76(4):520–525. PubMed CrossRef
  53. Wittekind DA, Kratzsch J, Mergl R, et al. Serum ghrelin is positively associated with physiological anxiety but negatively associated with pathological anxiety in humans: data from a large community-based study. Psychoneuroendocrinology. 2022;140:105728. PubMed CrossRef
  54. Sysko R, Glasofer DR, Hildebrandt T, et al. The eating disorder assessment for DSM-5 (EDA-5): Development and validation of a structured interview for feeding and eating disorders. Int J Eat Disord. 2015;48(5):452–463. PubMed CrossRef
  55. Kaufman J, Birmaher B, Brent D, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980–988. PubMed CrossRef
  56. Bryant-Waugh R, Micali N, Cooke L, et al. Development of the Pica, ARFID, and Rumination Disorder Interview, a multi-informant, semi-structured interview of feeding disorders across the lifespan: a pilot study for ages 10–22. Int J Eat Disord. 2019;52(4):378–387. PubMed CrossRef
  57. Harshman SG, Jo J, Kuhnle M, et al. A moving target: how we define avoidant/restrictive food intake disorder can double its prevalence. J Clin Psychiatry. 2021;82(5):20m13831. PubMed CrossRef
  58. Fairburn CG, Beglin SJ. Assessment of eating disorders: interview or self-report questionnaire? Int J Eat Disord. 1994;16(4):363–370. PubMed CrossRef
  59. Spielberger CD. Preliminary Manual for the State-Trait Personality Inventory. Tampa, FL: Human Resources Institute, University South Florida; published online 1996.
  60. Spielberger CD, Edwards CD, Lushene RE, et al Preliminary Test Manual for the State-Trait Anxiety Inventory for Children. Palo Alto, CA: Consulting Psychologists Press; published online 1973.
  61. An inventory for measuring clinical anxiety: Psychometric properties. - PsycNET. APA website. https://content.apa.org/record/1989-10559-001. Accessed August 10, 2021.
  62. Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken). 2011;63(suppl 11):S467–S472. PubMed CrossRef
  63. Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141–173. PubMed CrossRef
  64. APA Dictionary of Psychology. APA website. https://dictionary.apa.org/. Accessed August 4, 2022.
  65. Rytwinski NK, Fresco DM, Heimberg RG, et al. Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale. Depress Anxiety. 2009;26(1):34–38. PubMed CrossRef
  66. Thomas JJ, Lawson EA, Micali N, et al. Avoidant/restrictive food intake disorder: a three-dimensional model of neurobiology with implications for etiology and treatment. Curr Psychiatry Rep. 2017;19(8):54. PubMed CrossRef
  67. Ghersi MS, Casas SM, Escudero C, et al. Ghrelin inhibited serotonin release from hippocampal slices. Peptides. 2011;32(11):2367–2371. PubMed CrossRef
  68. Brunetti L, Recinella L, Orlando G, et al. Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus. Eur J Pharmacol. 2002;454(2-3):189–192. PubMed CrossRef
  69. Daviu N, Füzesi T, Rosenegger DG, et al. Paraventricular nucleus CRH neurons encode stress controllability and regulate defensive behavior selection. Nat Neurosci. 2020;23(3):398–410. PubMed CrossRef
  70. Labarthe A, Fiquet O, Hassouna R, et al. Ghrelin-derived peptides: a link between appetite/reward, GH axis, and psychiatric disorders? Front Endocrinol (Lausanne). 2014;5:163. PubMed CrossRef
  71. Howick K, Griffin BT, Cryan JF, et al. From belly to brain: targeting the ghrelin receptor in appetite and food intake regulation. Int J Mol Sci. 2017;18(2):273. PubMed CrossRef
  72. Müller TD, Nogueiras R, Andermann ML, et al. Ghrelin. Mol Metab. 2015;4(6):437–460. PubMed CrossRef
  73. De Vriese C, Gregoire F, Lema-Kisoka R, et al. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology. 2004;145(11):4997–5005. PubMed CrossRef
  74. Lee FS, Heimer H, Giedd JN, et al. Adolescent mental health—opportunity and obligation. Science. 2014;346(6209):547–549. PubMed CrossRef
  75. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602. PubMed CrossRef
Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

Save Save

Share Share

Cite Cite

Vol 85 • 2024 • Number 3

Read the Current Issue

Editorial

Focus on Women’s Mental Health: Twenty Years and Counting

Original Research

Esmethadone in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants

Commentary

Can Our Collective Experiences As Clinicians Improve Mental Health Care?

Original Research

Prescription Opioid Use Disorder in US Adults Reporting Prescription Opioid Use

Original Research

Symptomatic Disorders Comorbid with Borderline Personality Disorder Over Time

Original Research

Aripiprazole Lauroxil Initiation Regimens
View current Issue

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe